loadpatents
Patent applications and USPTO patent grants for Hu; Yunfeng Eric.The latest application filed is for "imidazopyrimidine derivatives".
Patent | Date |
---|---|
Imidazopyrimidine Derivatives App 20220241281 - Chin; Gregory ;   et al. | 2022-08-04 |
Quinazoline compounds Grant 11,304,948 - Baszczynski , et al. April 19, 2 | 2022-04-19 |
Imidazopyrimidine derivatives Grant 11,179,397 - Chin , et al. November 23, 2 | 2021-11-23 |
Therapeutic Compounds App 20210009555 - Brizgys; Gediminas ;   et al. | 2021-01-14 |
Quinazoline Compounds App 20200360383 - Baszczynski; Ondrej ;   et al. | 2020-11-19 |
Imidazopyrimidine Derivatives App 20200108071 - Chin; Gregory ;   et al. | 2020-04-09 |
Quinazoline compounds Grant 10,548,898 - Baszczynski , et al. Fe | 2020-02-04 |
Compounds for the treatment of hepatitis B virus infection Grant 10,442,804 - Aktoudianakis , et al. Oc | 2019-10-15 |
Compounds for the treatment of HIV Grant 10,370,358 - Bondy , et al. | 2019-08-06 |
Quinazoline Compounds App 20190134035 - Baszczynski; Ondrej ;   et al. | 2019-05-09 |
Quinazoline compounds Grant 10,206,926 - Baszczynski , et al. Feb | 2019-02-19 |
Therapeutic Compounds App 20180273508 - Brizgys; Gediminas ;   et al. | 2018-09-27 |
Compounds and combinations for the treatment of HIV Grant 10,059,697 - Cihlar , et al. August 28, 2 | 2018-08-28 |
Compounds For the Treatment of HIV App 20180194746 - Bondy; Steven S. ;   et al. | 2018-07-12 |
Therapeutic compounds Grant 9,951,043 - Brizgys , et al. April 24, 2 | 2018-04-24 |
Compounds for the treatment of HIV Grant 9,944,619 - Bondy , et al. April 17, 2 | 2018-04-17 |
Therapeutic compounds Grant 9,873,680 - Brizgys , et al. January 23, 2 | 2018-01-23 |
Quinazoline Compounds App 20170354656 - Baszczynski; Ondrej ;   et al. | 2017-12-14 |
Quinazoline compounds Grant 9,730,936 - August 15, 2 | 2017-08-15 |
Compounds For The Treatment Of Hiv App 20170137405 - Bondy; Steven S. ;   et al. | 2017-05-18 |
Compounds And Combinations For The Treatment Of Hiv App 20170114048 - Cihlar; Tomas ;   et al. | 2017-04-27 |
Isoquinoline compounds Grant 9,624,195 - Hu , et al. April 18, 2 | 2017-04-18 |
Compounds for the treatment of HIV Grant 9,540,343 - Bondy , et al. January 10, 2 | 2017-01-10 |
Quinazoline Compounds App 20160250215 - BASZCZYNSKI; Ondrej ;   et al. | 2016-09-01 |
Isoquinoline Compounds App 20160237062 - Hu; Yunfeng Eric ;   et al. | 2016-08-18 |
Therapeutic Compounds App 20160108030 - Brizgys; Gediminas ;   et al. | 2016-04-21 |
Therapeutic Compounds App 20160083368 - Brizgys; Gediminas ;   et al. | 2016-03-24 |
Therapeutic compounds Grant 9,050,344 - Brizgys , et al. June 9, 2 | 2015-06-09 |
Therapeutic compounds Grant 9,012,441 - Bondy , et al. April 21, 2 | 2015-04-21 |
Therapeutic Compounds App 20140303164 - BRIZGYS; Gediminas ;   et al. | 2014-10-09 |
Therapeutic Compounds App 20140296266 - HU; Yunfeng Eric ;   et al. | 2014-10-02 |
Therapeutic Compounds App 20140221417 - BONDY; Steven S. ;   et al. | 2014-08-07 |
Therapeutic Compounds App 20140221347 - BRIZGYS; Gediminas ;   et al. | 2014-08-07 |
Therapeutic Compounds App 20140221346 - HALCOMB; Randall L. ;   et al. | 2014-08-07 |
Compounds For The Treatment Of Hiv App 20140142085 - Bondy; Steven S. ;   et al. | 2014-05-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.